Liquid Biopsy DNA Preimplantation Genetic Testing (PGT) Clinical Trials

Brand Name:Orsin
Minimum Order Quantity:100
Payment Terms:L/C, D/A, D/P, T/T, Western Union
Place of Origin:China
Price:Negotiation
application:Clinical Trials
Contact Now

Add to Cart

Verified Supplier
Location: Shanghai Shanghai China
Address: Building A, No.599 Wanhua Road, Zhelin Town, Fengxian Area, Shanghai, China
Supplier`s last login times: within 1 hours
Product Details Company Profile
Product Details

  • Product Description: Cell-Free DNA (cfDNA) Collection and Preservation System by Orsin Medical Technology

    • 1. Product Description



    • Orsin Medical Technology’s Cell-Free DNA (cfDNA) Collection and Preservation System offers a reliable, non-invasive solution for the efficient stabilization and transport of high-quality cfDNA samples. Designed for clinical research, liquid biopsy, and molecular diagnostics, our proprietary technology ensures the integrity of cfDNA from blood samples, minimizing degradation and contamination.

      Key Features:
      Room-Temperature Stability – Eliminates the need for cold chain transport, reducing costs and logistical challenges.
      High Yield & Purity – Preserves cfDNA fragments for accurate downstream analysis (NGS, PCR, etc.).
      Clinically Validated – Optimized for compatibility with major diagnostic platforms.
      User-Friendly – Simple blood collection and seamless integration into lab workflows.

      Ideal for cancer screening, prenatal testing, and disease monitoring, Orsin’s cfDNA system empowers precision medicine with robust, reproducible results.


    • 2. Specification



      ParameterDescription/Options
      Tube Cap ColorRed, Lavender (Purple), Green, Gray, Blue, Yellow, Black, etc.
      Additive TypeNone (Clot activator), EDTA, Heparin, Sodium Citrate, Sodium Fluoride, etc.
      Clinical UseSerum separation, Hematology, Coagulation, Chemistry, Glucose, Blood Bank, etc.
      Nominal Volume2ml, 3ml, 4ml, 5ml, 6ml, 7ml, 8ml, 10ml, etc.
      Draw Volume Range±10% of nominal volume (e.g., 4.5-5.5ml for 5ml tube)
      Tube Diameter13mm, 16mm (standard adult size)
      Tube Length75mm, 100mm, etc.
      MaterialPET plastic, Glass
      SterilizationGamma irradiation, EO Gas
      Expiry PeriodTypically 12-36 months (from date of manufacture)
      Hemolysis Rate≤0.1% (for most chemistry tubes)
      Clotting Time30 mins (for serum tubes with clot activator)
      Centrifuge Speed1300-2200g (tube material dependent)
      Safety FeaturesHemogard™ closure, BD-PTS, Needle protection system
      CertificationsISO 6710, CE Marked, FDA 510(k)

      Common Parameters by Tube Color (Example):


      Cap ColorAdditiveMixingInversion CountClinical Applications
      RedNone/Clot activator5-6Serum chemistry, Immunology
      LavenderK2/K3 EDTA8-10×8-10Hematology (CBC, Blood Smear)
      GreenLithium Heparin8-10×8-10Plasma chemistry, STAT tests
      GrayNaF/K Oxalate8-10×8-10Glucose tolerance, Alcohol tests
      BlueSodium Citrate3-4×3-4Coagulation tests (PT, APTT)

      3 . Application


      1. Oncology & Cancer Management

    • Early Cancer Detection – Isolate tumor-derived cfDNA (ctDNA) for multi-cancer screening (e.g., lung, breast, colorectal).

    • Minimal Residual Disease (MRD) Monitoring – Track recurrence post-surgery/chemotherapy with high sensitivity.

    • Therapy Selection & Resistance – Profile mutations (e.g., EGFR, KRAS) to guide targeted therapies.

    • Liquid Biopsy – Alternative to invasive tissue biopsies for metastatic or hard-to-access tumors.

    • Compatible Tests: NGS panels, ddPCR, methylation profiling.

      2. Prenatal & Reproductive Health

    • Non-Invasive Prenatal Testing (NIPT) – Detect fetal chromosomal abnormalities (e.g., trisomy 21, 18, 13) from maternal blood.

    • Preimplantation Genetic Testing (PGT) – Support IVF embryo screening.

    • Preeclampsia Risk Assessment – Analyze placental cfDNA for early预警.

    • 3. Transplant Medicine

    • Organ Rejection Monitoring – Detect donor-derived cfDNA (dd-cfDNA) in transplant recipients (e.g., kidney, heart, liver).

    • Graft-versus-Host Disease (GVHD) – Monitor post-hematopoietic stem cell transplantation (HSCT).

    • Pathogen Detection – Identify microbial cfDNA in sepsis or occult infections (e.g., TB, CMV).

    • Autoimmune Disease Research – Study cfDNA release patterns in lupus, rheumatoid arthritis, etc.

    • 5. Neurological & Chronic Diseases

    • Neurodegenerative Disorders – Investigate cfDNA biomarkers for Alzheimer’s, Parkinson’s.

    • Cardiovascular Risk – Correlate cfDNA levels with myocardial injury or stroke.

    • 6. Research & Drug Development

    • Biomarker Discovery – Explore novel cfDNA signatures for diagnostics/therapeutics.

    • Clinical Trials – Standardize sample collection for multicenter studies.

    • 4. Infectious Diseases & Immunology

    • Pathogen Detection – Identify microbial cfDNA in sepsis or occult infections (e.g., TB, CMV).

    • Autoimmune Disease Research – Study cfDNA release patterns in lupus, rheumatoid arthritis, etc.

    • 5. Neurological & Chronic Diseases

    • Neurodegenerative Disorders – Investigate cfDNA biomarkers for Alzheimer’s, Parkinson’s.

    • Cardiovascular Risk – Correlate cfDNA levels with myocardial injury or stroke.

    • 6. Research & Drug Development

    • Biomarker Discovery – Explore novel cfDNA signatures for diagnostics/therapeutics.

    • Clinical Trials – Standardize sample collection for multicenter studies.

China Liquid Biopsy  DNA Preimplantation Genetic Testing (PGT)  Clinical Trials supplier

Liquid Biopsy DNA Preimplantation Genetic Testing (PGT) Clinical Trials

Inquiry Cart 0